Analysts await Unilife Corporation (NASDAQ:UNIS) to report earnings on May, 09 for the fiscal quarter ending Mar 2016.

At the moment 5 analysts are watching Unilife Corporation (NASDAQ:UNIS), 0 rate it “Buy”, 1 “Outperform”, 4 “Underperform”, 0 “Sell”, while 0 “Hold”.

Looking forward, for the quarter ending Dec-16, 1 analyst has a mean sales target of 3.50 million. For the quarter ending Mar-16, 1 analyst has a mean sales target of 4.00 million whilst for the year ending Jun-16, 2 analysts have a mean target of 15.85 million.

In terms of earnings per share, 1 analyst has a -0.09 EPS mean target for the quarter ending Dec-16, for the quarter ending Mar-16, 1 analyst has a -0.10 EPS mean target and for the quarter ending Mar-16 there are 2 estimates of -0.49 EPS.

The biggest institutional shareholders in Unilife Corporation include J P Morgan Asset Management (UK) Ltd which owns 8 million shares in the company valued at $4.00 million. J.P. Morgan Investment Management Inc is the second biggest holder with 7 million shares currently valued at 3.46 million whilst Vanguard Group Inc has 4 million shares valued at 1.86 million.

Total shares held by institutions as of the most recent company filings are 37,037,105 with a reported 1,226,748 bought and 887,181 sold. These holdings make up 22.22% of the company’s outstanding shares.

Currently insiders hold 15,683,510 shares in the business which makes up 9.42% of shares. The biggest holder currently is Mr. Alan Shortall who owns 6,572,240 shares (3.95% of those outstanding), whilst Dr. Ramin Mojdehbakhsh, PhD holds 4,522,167 (2.71% of shares outstanding) and Mr. Dennis P. Pyers holds 455,303 (0.27% of shares outstanding).

The stock decreased 3.3333% or $0.0175 during the last trading session, hitting $0.9200. Unilife Corporation (NASDAQ:UNIS) has risen 1.09% over the past 6 months and is uptrending.